Skip to main content
Caplight Logo









Epipal

Epipal

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://epipalapp.com/

Last Round

Grant

Jun 6, 2022

Total Funding Raised

$30,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Epipal is a healthcare technology company that provides a mobile application for seizure detection, epilepsy management, and collaborative care coordination for families and caregivers.

Sector

Healthcare & Life Sciences

Verticals

Health IoT, Medical Devices, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Keywords

seizure detectionepilepsy managementmHealthwearable sensordigital healthemergency alert systemtonic-clonic seizureremote patient monitoringRPMmedication trackingcollaborative carehealth IoTfall detectioncaregiver appseizure tracker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epipal Comparables

Compare Epipal with similar companies based on industry and business-model similarity.

Epipal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EpiWatch, Inc.
92%
SeizAlarm
90%
Smart Monitor
86%

Epipal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 6, 2022
AcceleratorSep 3, 2020

Epipal Investors

Notable investors and investment history

Epipal investors
InvestorRounds
Epilepsy FoundationGrant
CREATE-XAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 247% MoM, reaching 2.5K.

  • May 12, 2026

    Monthly visitors increased 36% MoM, reaching 6.5K.

Epipal Filings

Explore SEC and related filing metadata, where available.

Epipal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Epipal's valuation, stock price, and market status.

Is Epipal a public or private company?

Epipal is a private company.

What is the current stock price of Epipal?

Epipal is a private company with no public stock price. Caplight tracks Epipal's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Epipal worth (valuation)?

Valuation information for Epipal is not publicly available.

Can I buy Epipal stock?

Epipal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Epipal's last funding round?

Epipal's most recent funding round was Grant on June 6, 2022.

Who are the main investors in Epipal?

Key investors in Epipal include Epilepsy Foundation, CREATE-X.

Will Epipal IPO soon?

No public IPO plans have been announced for Epipal.

How can I track Epipal secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epipal's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range1
Year Founded2018
Last FundingJun 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?